Latest Gannet BioChem News & Updates

See the latest news and media coverage for Gannet BioChem. We track all announcements, press releases, and industry mentions in real time, all in one place.

Company icon
Gannet BioChem

Specialized CDMO for polymer science in therapeutics

gannetbiochem.com
Headquarters
Huntsville, United States
Founded year
1998
Company type
Private company
Number of employees
80–200

Last updated

Latest news about Gannet BioChem

In short: Gannet BioChem launched as an independent CDMO after its acquisition by Ampersand Capital Partners and significantly expanded its capabilities.

Company announcements

Gannet BioChem

Gannet BioChem acquires Laysan Bio

The acquisition expands activated polymer and bioconjugation capabilities, enhancing support from early development to GMP manufacturing. It aligns with Gannet BioChem's strategy.

Gannet BioChem

Gannet BioChem achieves SBTi validation for climate targets

The company commits to reducing Scope 1 and 2 GHG emissions 63% by 2035 from 2020 baseline and measuring Scope 3 emissions. CEO Nicholas Shackley highlights environmental responsibility.

Unlock all announcements with a

Media coverage

The Bakersfield Californian

Life Sciences Innovator Dr. Art Tipton Joins Gannet BioChem Board

Huntsville, AL, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Gannet BioChem, a leading specialty chemical Contract Development and Manufacturing Organization (CDMO) backed by Boston-based private equity...

Unlock all articles with a

Never miss news about Gannet BioChem

Track Gannet BioChem and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trending companies

Discover what's making headlines across other trending companies.